← SynDRA
SRT-1720
SynDRA canonical compound SYN0051615 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | SIRT1 |
|---|
| Mechanism of action | SIRT activator |
|---|
All known targets
Mechanisms of action (all sources)
- SIRT1 ACTIVATOR
- SIRT activator
Cross-references
Synonyms
- PMITPQ-carboxamide
- RefChem:926645
- DX3FHY76FZ
- SRT-1720 free base
- C25H23N7OS
- IASPBORHOMBZMY-UHFFFAOYSA-N
- MFCD14584468
- UNII-DX3FHY76FZ
- SCHEMBL963877
- GTPL7703
- orb1302094
- SCHEMBL29488567
- EX-A033
- GLXC-21231
- EX-A7228
- SRT1720?
- BDBM50228363
- AKOS016001425
- CS-0437
- FP41292
- SB19332
- NCGC00182052-01
- NCGC00182052-02
- NCGC00182052-03
- NCGC00182052-06
- NCGC00182052-12
- NCGC00182052-18
- AC-35736
- AS-17063
- HY-10532
- DB-079335
- T5096
- BRD-K95926480-003-03-6
- F3390-0301
- SRT1720
- Tafluprost enone
- AS-35151
- SRT-1720, SRT 1720, 1001645-58-4
- HY-15145
Look up SRT-1720 in the interactive SynDRA portal →